Subcutaneous implant of mifespristone and use thereof in treatment of endometriosis
OA: closed
Abstract
The present invention provides one kind of subdermal embedded mifepristone preparation containing mifepristone in effective treating amount and mifepristone holding sac. The sac has pharmaceutically acceptable polymer as basic material and dispersed pore creating agent, and the polymer may be polylactic acid, polylactide, polylactic acid-hydroxyacetic acid, polycaprolactone, etc. and is preferably polycaprolactone. The present invention also provides the use of the subdermal embedded mifepristone preparation in preparing medicine for treating endometriosis.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-07T06:07:59.301721+00:00